Early Life and Education
Pablo Legorreta was born in Mexico and later became a U.S. citizen. He earned a Bachelor of Science degree in industrial engineering from Universidad Iberoamericana in Mexico City.
Rise to Success
Legorreta began his career at Lazard Frères, where he gained experience in mergers and acquisitions. In 1996, he founded Royalty Pharma, which revolutionized the financing of drug development by acquiring pharmaceutical royalty streams. Under his leadership, Royalty Pharma has become the world's largest acquirer of pharmaceutical royalty streams, deploying over $25 billion to support research across academic institutions, nonprofits, biotech firms, and global pharmaceutical companies. The company went public in 2020.
Key Business Strategies
Legorreta's primary business venture is Royalty Pharma, a company specializing in acquiring pharmaceutical royalty streams. This innovative approach has allowed Royalty Pharma to collect revenue from blockbuster drugs like Humira, Imbruvica, and Lyrica. His strategy includes acquiring royalties from drugs in development and funding research and development. He also co-founded Pharmakon Advisors, a leading provider of debt capital to the life sciences industry.
Philanthropy
Legorreta and his wife, Almudena, are involved in philanthropy. They have made significant donations to medical research institutions, including a $25 million gift to Brown University's Legorreta Cancer Center. They also contributed $5 million to Brigham and Women's Hospital for kidney transplantation research. Additionally, Legorreta founded and chairs Alianza Médica para la Salud, a non-profit organization focused on enhancing healthcare education in Latin America.